Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
9,329,591
-
Shares change
-
+7,061,082
-
Total reported value, excl. options
-
$37,876,000
-
Value change
-
+$30,074,098
-
Number of buys
-
28
-
Number of sells
-
8
-
Price
-
$4.06
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2017
As of 31 Dec 2017 Viking Therapeutics, Inc. - COMMON STOCK (VKTX) had 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,329,591 shares of stock of the company.
Largest 10 holders included SPHERA FUNDS MANAGEMENT LTD., Sio Capital Management, LLC, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Park West Asset Management LLC, Opaleye Management Inc., PURA VIDA INVESTMENTS, LLC, EAM Investors, LLC, and EAM Global Investors LLC.
This table shows 32 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.